Advertisement

American College of Cardiology conference organizers cancel the highly anticipated presentation of preliminary results from Boston Scientific's PREVAIL study after the company leaks the data ahead of time.

American College of Cardiology conference 2013 logo

Medical device giant Boston Scientific (NYSE:BSX) will not present its highly anticipated PREVAIL clinical trial results at the American College of Cardiology conference as planned this morning after the presentation was canceled when the company leaked the data ahead of time.

Boston Scientific leaked a press release to its investors this morning, breaking an embargo on the study that was meant to be lifted during the presentation.

Advertisement
Advertisement